semaglutide california banned Drugmakers battle pharmacies over compounded Ozempic and Zepbound : Shots FDA warns consumers not to

Californias Board of Pharmacy was not meaningfully consulted during drafting

Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credit: AI Updated Jul 9, 2026 | 08:14 AM IST Summary Novo Nordisk has recently demonstrated interest in the manufacture of GLP-1 implant that could keep delivering semaglutide for several months continuously

injected once daily Adlyxin (lixisenatide) Short-acting

Retatrutide + Cagrilintide: Quad-Pathway Stack GLP-1, GIP, glucagon, plus amylin four metabolic axes in one stack